Neuroprotective Effects of a Novel Antioxidant Mixture Twendee X in Mouse Stroke Model

J Stroke Cerebrovasc Dis. 2017 Jun;26(6):1191-1196. doi: 10.1016/j.jstrokecerebrovasdis.2017.01.003. Epub 2017 Feb 9.

Abstract

Background: Oxidative stress and inflammation are important aggravating factors in acute ischemic stroke.

Methods: In the present study, the neuroprotective effects of a novel antioxidant mixture Twendee X containing multiple antioxidative ingredients, such as coenzyme Q10, ascorbic acid, and cystine, were evaluated. After the pretreatment of a vehicle or Twendee X (20 mg/kg/d) for 14 days, mice were subjected to transient middle cerebral artery occlusion for 60 minutes and further treated with vehicle or Twendee X for 1 or 5 days.

Results: Twendee X administration reduced the infarct size, and reduced oxidative stress markers such as 8-hydroxy-2'-deoxyguanosine, 4-hydroxy-2-nonenal, and Nε-(carboxymethyl) lysine (one of advanced glycation end products), as well as inflammatory markers such as ionized calcium binding adapter molecule-1, tumor necrosis factor-α, and monocyte chemotactic protein-1.

Conclusions: In the present study, the neuroprotective effects of Twendee X were shown on transient middle cerebral artery occlusion mice via antioxidative and anti-inflammatory pathways, providing a potential of Twendee X as one preventive and therapeutic treatment.

Keywords: Ischemic stroke; anti-inflammatory; antioxidative; middle cerebral artery occlusion; mouse.

MeSH terms

  • 8-Hydroxy-2'-Deoxyguanosine
  • Aldehydes / metabolism
  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Antioxidants / pharmacology*
  • Biomarkers / metabolism
  • Brain / drug effects*
  • Brain / metabolism
  • Brain / pathology
  • Deoxyguanosine / analogs & derivatives
  • Deoxyguanosine / metabolism
  • Disease Models, Animal
  • Glycation End Products, Advanced / metabolism
  • Infarction, Middle Cerebral Artery / metabolism
  • Infarction, Middle Cerebral Artery / pathology
  • Infarction, Middle Cerebral Artery / prevention & control*
  • Inflammation Mediators / metabolism
  • Lysine / analogs & derivatives
  • Lysine / metabolism
  • Male
  • Mice, Inbred C57BL
  • Neuroprotective Agents / pharmacology*
  • Oxidative Stress / drug effects*
  • Time Factors

Substances

  • Aldehydes
  • Anti-Inflammatory Agents
  • Antioxidants
  • Biomarkers
  • Glycation End Products, Advanced
  • Inflammation Mediators
  • Neuroprotective Agents
  • N(6)-carboxymethyllysine
  • 8-Hydroxy-2'-Deoxyguanosine
  • Deoxyguanosine
  • 4-hydroxy-2-nonenal
  • Lysine